HOS (人骨肉瘤细胞)(STR鉴定正确）

参考文献

• A novel photothermally controlled multifunctional scaffold for clinical treatment of osteosarcoma and tissue regeneration(2020/06/01)

  作者：Liang Ma, Xiaobo Feng, Hang Liang

  期刊：Materials Today

  DOI：10.1016/j.mattod.2019.12.005

  影响因子 ：24.200

  引用产品：CL-0360 CL-0378

• lncRNA MELTF-AS1 facilitates osteosarcoma metastasis by modulating MMP14 expression(2021/08/26)

  作者：Lei Ding, Taiyuan Liu, Yuan Qu

  期刊：Molecular Therapy-Nucleic Acids

  DOI：10.1016/j.omtn.2021.08.022

  影响因子 ：8.800

  引用产品：CL-0157 CL-0202 CL-0236 CL-0360

• Exploring the immune microenvironment of osteosarcoma through T cell exhaustion-associated gene expression: a study on prognosis prediction(2023/12/15)

  作者：Junchao Zhu, Jinghong Yuan, Shahrzad Arya

  期刊：Frontiers in Immunology

  DOI：10.3389/fimmu.2023.1265098

  影响因子 ：7.300

  引用产品：CL-0360

• Multi-omics analysis reveals cuproptosis and mitochondria-based signature for assessing prognosis and immune landscape in osteosarcoma(2024/01/05)

  作者：Chenguang Jia, Mei Liu, Liming Yao

  期刊：Frontiers in Immunology

  DOI：10.3389/fimmu.2023.1280945

  影响因子 ：7.300

  引用产品：CL-0360

• A novel molecular signature for predicting prognosis and immunotherapy response in osteosarcoma based on tumor-infiltrating cell marker genes(2023/04/06)

  作者：Haijun Tang, Shangyu Liu, Xiaoting Luo

  期刊：Frontiers in Immunology

  DOI：10.3389/fimmu.2023.1150588

  影响因子 ：7.300

  引用产品：CL-0360

• Sirt1 modulates H3 phosphorylation and facilitates osteosarcoma cell autophagy(2019/08/07)

  作者：Hongliang Ying, Boda Ying, Jinrui Zhang

  期刊：Artificial Cells Nanomedicine and Biotechnology

  DOI：10.1080/21691401.2019.1648280

  影响因子 ：5.800

  引用产品：CL-0157 CL-0202 CL-0360

• Ten-gene signature reveals the significance of clinical prognosis and immuno-correlation of osteosarcoma and study on novel skeleton inhibitors regarding MMP9(2021/07/14)

  作者：Weihang Li, Ziyi Ding, Dong Wang

  期刊：Cancer Cell International

  DOI：10.1186/s12935-021-02041-4

  影响因子 ：5.800

  引用产品：CL-0157 CL-0360 PM150210B

• ADAM10 promotes cell growth, migration, and invasion in osteosarcoma via regulating E-cadherin/β-catenin signaling pathway and is regulated by miR-122-5p(2020/03/30)

  作者：Quan Yuan, Honghao Yu, Jianhua Chen

  期刊：Cancer Cell International

  DOI：10.1186/s12935-020-01174-2

  影响因子 ：5.800

  引用产品：CL-0202 CL-0360 PM150710

• What role does GPR65 play in the progression of osteosarcoma? Its mechanism and clinical significance(2024/01/13)

  作者：Jin Qi, Sihang Liu, Zhirui Zhang

  期刊：Cancer Cell International

  DOI：10.1186/s12935-024-03216-5

  影响因子 ：5.800

  引用产品：CL-0360

• A1BG-AS1 promotes the biological functions of osteosarcoma cells via regulating the microRNA-148a-3p/USP22 axis and stabilizing the expression of SIRT1 through deubiquitinase function(2023/10/03)

  作者：Xiuxin Han, Mengfan Yin, Chen Gong

  期刊：EXPERT OPINION ON THERAPEUTIC TARGETS

  DOI：10.1080/14728222.2023.2263908

  影响因子 ：5.800

  引用产品：CL-0360

• Solasonine Inhibits Cancer Stemness and Metastasis by Modulating Glucose Metabolism via Wnt/β-Catenin/Snail Pathway in Osteosarcoma(2023/06/28)

  作者：Bangjun Wang, Yi Zhou, Peng Zhang

  期刊：AMERICAN JOURNAL OF CHINESE MEDICINE

  DOI：10.1142/S0192415X23500593

  影响因子 ：5.700

  引用产品：CL-0236 CL-0360

• Anoikis patterns exhibit distinct prognostic and immune landscapes in Osteosarcoma(2023/01/09)

  作者：Zhao Zhang, Zhijie Zhu, Jun Fu

  期刊：INTERNATIONAL IMMUNOPHARMACOLOGY

  DOI：10.1016/j.intimp.2023.109684

  影响因子 ：5.600

  引用产品：CL-0157 CL-0360

• ATRX loss suppresses the type I interferon response in sarcoma cells through chromatin remodeling(2023/08/15)

  作者：Xinrui Wang, Zige Jin, Shanshan Tang

  期刊：American Journal of Cancer Research

  DOI：PMID:37693131

  影响因子 ：5.300

  引用产品：CL-0005 CL-0157 CL-0202 CL-0236 CL-0360

• Circular RNA hsa_circ_001350 contributes to osteosarcoma progression by regulating microRNA-578/CCR4-NOT transcription complex and subunit 7/Wnt signaling(2023/06/15)

  作者：Rujin Xu, Xingyuan Ci, Fang He

  期刊：American Journal of Cancer Research

  DOI：PMID:37424831

  影响因子 ：5.300

  引用产品：CL-0157 CL-0202 CL-0236 CL-0360

• Sulfatinib, a novel multi-targeted tyrosine kinase inhibitor of FGFR1, CSF1R, and VEGFR1–3, suppresses osteosarcoma proliferation and invasion via dual role in tumor cells and tumor microenvironment(2023/06/08)

  作者：Song Liao, Jianxiong Li, Song Gao

  期刊：Frontiers in Oncology

  DOI：10.3389/fonc.2023.1158857

  影响因子 ：4.700

  引用产品：CL-0157 CL-0190 CL-0236 CL-0360 CL-0371

• hsa_circ_0020378 regulating miR-339-3p/COL1A1 promotes osteosarcoma progression(2023/11/18)

  作者：Liang Liu, Wenze Huang

  期刊：CANCER BIOLOGY & THERAPY

  DOI：10.1080/15384047.2023.2274120

  影响因子 ：3.600

  引用产品：CL-0360

• Hsa_circ_0097271 Knockdown Attenuates Osteosarcoma Progression via Regulating miR-640/MCAM Pathway(2022/10/26)

  作者：Peng Sun, Xuan Yang

  期刊：DISEASE MARKERS

  DOI：10.1155/2022/8084034

  影响因子 ：3.464

  引用产品：CL-0360

• Circular RNA circDOCK1 contributes to osteosarcoma progression by acting as a ceRNA for miR-936 to regulate LEF1(2022/09/09)

  作者：Gang Xu, Haijiao Zhang, Yuxia Shi

  期刊：Journal of Bone Oncology

  DOI：10.1016/j.jbo.2022.100453

  影响因子 ：3.400

  引用产品：CL-0236 CL-0360 CM-0236 CM-0360 CP-H082 PB180120

• A New 7-azaindole Structure Analog: Molecular Docking, Synthesis and Preliminary Biological Activity in vitro for Anticancer(2022/09/09)

  作者：Yifeng Zhan, Hang Tong, Shibo He

  期刊：CHEMISTRY & BIODIVERSITY

  DOI：10.1002/cbdv.202200692

  影响因子 ：2.900

  引用产品：CL-0137 CL-0360

• Farnesyl diphosphate synthase promotes cell proliferation by regulating gene expression and alternative splicing profiles in HeLa cells(2023/02/28)

  作者：Lijuan Wang, Zhigang Chen, Dong Chen

  期刊：Oncology Letters

  DOI：10.3892/ol.2023.13731

  影响因子 ：2.900

  引用产品：CL-0350 CL-0360 PM150410

• Hsa_circ_0000591 drives osteosarcoma glycolysis and progression by sequestering miR-194-5p and elevating HK2 expression(2023/02/21)

  作者：Dawei Wang, Yang Wang, Huadong Wang

  期刊：CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

  DOI：10.1111/1440-1681.13763

  影响因子 ：2.900

  引用产品：CL-0157 CL-0236 CL-0360 PB180120

• Exosomal miR-331-3p derived from chemoresistant osteosarcoma cells induces chemoresistance through autophagy(2023/11/22)

  作者：Chenyang Meng, Yun Yang, Wei Feng

  期刊：Journal of Orthopaedic Surgery and Research

  DOI：10.1186/s13018-023-04338-8

  影响因子 ：2.600

  引用产品：CL-0360

• ARHGAP44-mediated regulation of the p53/C-myc/Cyclin D1 pathway in modulating the malignant biological behavior of osteosarcoma cells(2023/11/29)

  作者：Shizhe Li, Jiancheng Xue, He Zhang

  期刊：Journal of Orthopaedic Surgery and Research

  DOI：10.1186/s13018-023-04406-z

  影响因子 ：2.600

  引用产品：CL-0360

• Circ_0003732 promotes osteosarcoma progression through regulating miR-377-3p/CPEB1 axis and Wnt/β-catenin signaling pathway(2022/01/01)

  作者：Zheng Zhou, Tang Liu, Zhihong Li

  期刊：Anti-Cancer Drugs

  DOI：10.1097/CAD.0000000000001206

  影响因子 ：2.389

  引用产品：CL-0236 CL-0360

• circATP2A2 promotes osteosarcoma progression by upregulating MYH9(2021/11/22)

  作者：Xin Cao, Xianfeng Meng, Peng Fu

  期刊：Open Medicine

  DOI：10.1515/med-2021-0370

  影响因子 ：2.100

  引用产品：CL-0202 CL-0236 CL-0360 PM150312

• Bavachin Induces Ferroptosis through the STAT3/P53/SLC7A11 Axis in Osteosarcoma Cells(2021/10/18)

  作者：Yi Luo, Xu Gao, Luetao Zou

  期刊：Oxidative Medicine and Cellular Longevity

  DOI：10.1155/2021/1783485

  影响因子 ：0.000

  引用产品：CL-0157 CL-0360

点击展开收起列表